F039 Controversies in Acne and Rosacea
DESCRIPTION
In this session, we will discuss the management of acne and rosacea with a focus on controversies surrounding who should have hormonal evaluation, how best to incorporate isotretinoin and hormonal therapies (e.g. spironolactone) as well as other new treatments into practice, the role of lasers and light therapy, and special considerations for patients with skin of color. This activity has been approved by the American Board of Dermatology (ABD) for up to 20 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Use of isotretinoin and hormonal therapy (e.g. spironolactone) in the treatment of acne by being able to explain controversies surrounding patient selection, dosing, and monitoring/side effects.
Examine the role of lasers and lights for acne and rosacea.
Summarize the management of acne and rosacea among patients with skin of color.
SCHEDULE
9:00 AM
Introduction and Welcome
John S. Barbieri, MD, MBA, FAAD
9:05 AM
Hormonal Therapy
Juliana Kim Choi, MD, PhD, FAAD
9:25 AM
Lasers and Lights for Acne and Rosacea
Emmy M. Graber, MD, MBA, FAAD
9:45 AM
Updates on Isotretinoin and Novel Topicals
John S. Barbieri, MD, MBA, FAAD
10:10 AM
Managing Acne and Rosacea in Patients with Skin of Color
Andrew F. Alexis, MPH, MD, FAAD
10:30 AM
Panel Discussion
DIRECTOR
John S. Barbieri, MD, MBA, FAAD
SPEAKERS
Andrew F. Alexis, MPH, MD, FAAD
Juliana Kim Choi, MD, PhD, FAAD
Emmy M. Graber, MD, MBA, FAAD
DISCLOSURES
Andrew F. Alexis, MPH, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Aerolase – Other(Equipment), Speaker(Honoraria); Allergan, Inc. – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria); Alphyn Biologics – Advisory Board(Honoraria); Alumis – Advisory Board(Fees); Amgen – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Botanix Pharmaceuticals – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Dermsquared – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Eli Lilly – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Speaker(Honoraria); Elsevier Inc. – Other(Other Financial Benefit); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Genentech, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); HairDays – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte Corporation – Consultant (1099 relationship)(Fees); Janssen Scientific Affairs, LLC – Consultant(Honoraria); Johnson and Johnson – Advisory Board(Honoraria), Speaker(Honoraria); L'Oréal France – Advisory Board(Honoraria), Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Leo Pharma Inc – Consultant(Fees); Leo Pharma Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Medscape – Other(Honoraria); Novartis – Advisory Board(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Speaker(Honoraria); RBC Consultants – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Sanova Works – Speaker(Honoraria); Scientis – Speaker(Honoraria); Springer Science & Business Media – Other(Other Financial Benefit); Symrise – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Fees); UpToDate, Inc. – Other(Other Financial Benefit); VeraDermics Inc. – Advisory Board(Honoraria); Wiley-Blackwell – Other(Other Financial Benefit);
John S. Barbieri, MD, MBA, FAAD
Alosa Health – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Honeydew Care – Consultant (1099 relationship)(Fees); Kenvue – Consultant (1099 relationship)(Fees); National Institutes of Health – Other(Grants/Research Funding); National Psoriasis Foundation – Other(Grants/Research Funding); Sagimet Biosciences – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); TWi Biotechnology, Inc. – Consultant (1099 relationship)(Fees);
Juliana Kim Choi, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Emmy M. Graber, MD, MBA, FAAD
Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); CeraVe – Speaker(Honoraria); Cutera – Speaker(Honoraria); Cutera, Inc. – Consultant(Honoraria), Stockholder(Stock); digital diagnostics – Consultant(Honoraria); Digital Diagnostics – Stockholder(Stock Options); Galderma – Speaker(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); Lipidor AB – Consultant(Honoraria); Ortho Dermatologics – Consultant(Honoraria), Investigator(Grants/Research Funding); WebMD – Consultant(Honoraria); WoltersKluwer Health – Other(Honoraria);